Updated Jul 16, 2026
Bello Akintunde Olatokumbo has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Bello Akintunde Olatokumbo is associated with Xilio Therapeutics, Inc. based on SEC filings dated around June 12, 2026. The available SEC context indicates involvement with Xilio Therapeutics but does not specify a formal title or role. There are no widely published biographical details available from public sources in the provided context beyond this SEC filing association.
| Role | Insider |
|---|---|
| Notability | 20/100 |
Bello Akintunde Olatokumbo is associated with Xilio Therapeutics, Inc. based on SEC filings dated around June 12, 2026. The available SEC context indicates involvement with Xilio Therapeutics but does not specify a formal title or role. There are no widely published biographical details available from public sources in the provided context beyond this SEC filing association.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Bello Akintunde Olatokumbo profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.